If you or a loved one gets pneumonia while in the hospital, doctors have to choose which antibiotic to use. Newer, often more expensive options are available, but do they actually work better? A new analysis of 10 studies involving 2,881 patients finds that newer antibiotics are no more effective than older generic ones at preventing death within 28 days. The death rates were essentially the same.
But here's the good news: the newer antibiotics were much gentler on the kidneys. Patients who got them had a 70% lower risk of kidney damage compared to those on older drugs like colistin. That's a big deal because kidney injury can lead to longer hospital stays and more complications.
The analysis also found that newer antibiotics were better at wiping out tough, drug-resistant bacteria. They were 50% more likely to clear carbapenem-resistant germs, which are a growing threat in hospitals.
Still, this is a meta-analysis, which means it combines results from several smaller studies. The quality of those studies varies, and the findings may not apply to every patient. But for now, the takeaway is clear: when it comes to saving lives, newer isn't necessarily better. But when it comes to protecting kidneys, newer antibiotics have a clear edge.